IceCure Medical director gets 166,577-unit stock grant

Ron’s reported post-transaction position comprised 333 ordinary shares and 176,131 RSUs as of November 2, 2026.

Available on EDGAR 11/02/2026 - 04:31 PM EST Accepted by SEC EDGAR 11/02/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

IceCure Medical Ltd. (ICCM) director Mayron Ron acquired 166,577 restricted share units (RSUs), granted August 11, 2026; all 166,577 vested immediately upon shareholder approval on November 2, 2026. His reported post-transaction holdings were 176,464 securities, comprising 333 ordinary shares and 176,131 RSUs as of November 2, 2026. The holdings were adjusted for the issuer’s 1-for-30 reverse share split effected June 4, 2026.

Insider Trade Summary

Grant/Award: 166,577 shares

Grant/Award 1 txn

Insider Mayron Ron

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1, F2	166,577	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 176,464 shares (Direct)

Footnotes (2)

1. F1. Represents 166,577 restricted share units ("RSUs") granted on August 11, 2026, of which 166,577 RSUs vested immediately upon shareholder approval of the grant on November 2, 2026.
2. F2. Represents (i) 333 ordinary shares and (ii) 176,131 RSUs (including the RSUs described in Footnote 1 above), of which 5,374 have vested and 170,757 remain unvested as of November 2, 2026. The holdings in clauses (i) and (ii) have been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026.

Key Figures

RSUs acquired: 166,577 RSUs Post-transaction holdings: 176,464 securities Ordinary shares held: 333 ordinary shares +2 more

5 metrics

RSUs acquired 166,577 RSUs Granted August 11, 2026; vested immediately upon shareholder approval on November 2, 2026

Post-transaction holdings 176,464 securities As of November 2, 2026

Ordinary shares held 333 ordinary shares Included in reported holdings as of November 2, 2026

RSUs held 176,131 RSUs Included in reported holdings as of November 2, 2026

Reverse share split 1-for-30 Effected June 4, 2026

Key Terms

restricted share units, vested, reverse share split

3 terms

restricted share units financial

"166,577 restricted share units ("RSUs") granted"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

vested financial

"166,577 RSUs vested immediately upon shareholder approval"

reverse share split technical

"Issuer's 1-for-30 reverse share split effected"

A reverse share split is when a company reduces the number of its shares outstanding by combining multiple shares into one, effectively increasing the price of each share. For investors, this can help improve the company's image or meet stock exchange listing requirements, but it does not change the total value of their investment. It’s similar to turning many small pieces of a puzzle into fewer larger pieces—nothing new is added or lost, just rearranged.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did IceCure Medical (ICCM) director Mayron Ron acquire?

Mayron Ron acquired 166,577 RSUs, granted August 11, 2026, which vested immediately upon shareholder approval on November 2, 2026.

What were Mayron Ron’s holdings in IceCure Medical (ICCM) after the transaction?

As of November 2, 2026, Ron’s reported holdings were 176,464 securities: 333 ordinary shares and 176,131 RSUs. The holdings were adjusted for the issuer’s 1-for-30 reverse share split effected June 4, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mayron Ron

(Last) (First) (Middle)

7 HA'ESHEL ST., PO BOX 3163

(Street)

CAESAREA 3079504

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
IceCure Medical Ltd. [ ICCM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/02/2026		A		166,577(1)	A	$0	176,464(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 166,577 restricted share units ("RSUs") granted on August 11, 2026, of which 166,577 RSUs vested immediately upon shareholder approval of the grant on November 2, 2026.

2. Represents (i) 333 ordinary shares and (ii) 176,131 RSUs (including the RSUs described in Footnote 1 above), of which 5,374 have vested and 170,757 remain unvested as of November 2, 2026. The holdings in clauses (i) and (ii) have been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026.

	/s/ Ron Mayron	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)